Only kinase-ligand complex structures with molecules targeting the ATP binding site in the DFG-in conformation were selected, such as type I and I 1 /2 inhibitors, to reduce the conformational space of the kinase structures. After filtering the 7,370 starting structures assembled from the KLIFS database, 2,553 protein kinase-ligand structures were chosen for this study.